Fulbright Lectureship in Biotechnologies at the University of Udine, Department of Medical and Biological Sciences (DSMB) – Molecular Biology Section, University of Udine
From the description:
The scholar will teach a single 12 weeks’ course of 3h-4h per week during the second semester (March-June) for undergraduate students of biotechnology and health care sciences.
The class will be composed of approximately 30 students. Lectures will be held in English and will focus on the molecular aspects of tumor biology as well as on their clinical impact or consequences.
The applicant is required to furnish a detailed program curriculum for the course indicating how he/she intends to structure the class, the topics discussed during the lectures, what is the final goal of the course and the modality of the final evaluation exam.
Proposal based on bioinformatics or mathematic approaches will not be taken into consideration.
The scholar will be hosted by the Molecular Biology Section of the Department of Medicine where he/she will be allowed to do research and collaborate with Italian colleagues.
On a voluntary basis the scholar could also hold a seminar to present his/her research work and a lecture to the Ph.D. students of the Department. In addition, a seminar at the University of Trieste or in other institutes (SISSA and ICGEB) in the nearby city of Trieste could also be arranged.
In addition to being a prestigious academic exchange program, the Fulbright Program is designed to expand and strengthen relationships between the people of the United States and citizens of other nations and to promote international understanding and cooperation. To support this mission, Fulbright Scholars will be asked to give public talks, mentor students, and otherwise engage with the host community, in addition to their primary activities.
GRANT LENGTH
Three, four or five months
GRANT DATES
Five-month grants must begin on March 1, 2020.
Four-month grants must begin on either March 1, 2020 or April 1, 2020.
Three-month grants must begin on April 1, 2020.